General information
  • Disease category Prostate Cancer (BASEC)
  • Recruitment status recruitment ongoing (BASEC/ICTRP)
  • Trial sites
    Basel
    (BASEC)
  • Contact Heike Püschel heike.pueschel@usb.ch (BASEC)
  • Data Source(s) BASEC: Import from 12.06.2025 ICTRP: N/A
  • Last update 12.06.2025 11:00
HumRes66233 | SNCTP000006225 | BASEC2024-02381

Radikale Prostatektomie mit oder ohne Entfernung der Lymphknoten

  • Disease category Prostate Cancer (BASEC)
  • Recruitment status recruitment ongoing (BASEC/ICTRP)
  • Trial sites
    Basel
    (BASEC)
  • Contact Heike Püschel heike.pueschel@usb.ch (BASEC)
  • Data Source(s) BASEC: Import from 12.06.2025 ICTRP: N/A
  • Last update 12.06.2025 11:00

Summary description of the study

Der aktuelle Standard bei der operativen Entfernung der Prostata ist die gleichzeitige Entfer-nung der Beckenlymphknoten, sofern ein erhöhtes Risiko für Krebsableger in den Lymphkno-ten besteht. Bislang ist aber unklar, ob die Entfernung der Beckenlymphknoten tatsächlich einen Vorteil in Bezug auf den Verlauf der Krebserkrankung darstellt. Zudem verlängert die Entfernung der Beckenlymphknoten die Operationszeit um gut eine Stunde und geht mit mehr Komplikationen einher. In dieser Studie untersuchen wir, ob sich eine Entfernung der Beckenlymphknoten auf die Entwicklung der Krankheit auswirkt.

(BASEC)

Intervention under investigation

radikale Prostatektomie mit/ohne Lymphknotenentfernung

(BASEC)

Disease under investigation

Prostatakarzinom

(BASEC)

Criteria for participation in trial
Any biopsy-proven WHO/ISUP grade groups III-V PCa ISUP grade group II and PSA > 20 ng/ml Any cT3 (MRI) PSMA-PET: negative staging for regional and distant metastasis WHO performance status 0-1 (BASEC)

Exclusion criteria
ISUP grade group I PCa and cT1 or cT2 (MRI) cT4 (MRI) PCa PSMA-PET: positive staging for local and distant metastases Any prior neoadjuvant, local or systemic treatment for PCa Previous PLND or pelvic radiotherapy (BASEC)

Trial sites

Basel

(BASEC)

not available

Sponsor

USB

(BASEC)

Contact

Contact Person Switzerland

Heike Püschel

0615565477

heike.pueschel@usb.ch

USB

(BASEC)

Scientific Information

not available

Name of the authorising ethics committee (for multicentre studies, only the lead committee)

Ethics Committee northwest/central Switzerland EKNZ

(BASEC)

Date of authorisation

03.01.2025

(BASEC)


ICTRP Trial ID
not available

Official title (approved by ethics committee)
Dissection 2.0 (BASEC)

Academic title
not available

Public title
not available

Disease under investigation
not available

Intervention under investigation
not available

Type of trial
not available

Trial design
not available

Inclusion/Exclusion criteria
not available

not available

Primary and secondary end points
not available

not available

Registration date
not available

Incorporation of the first participant
not available

Secondary sponsors
not available

Additional contacts
not available

Secondary trial IDs
not available

Results-Individual Participant Data (IPD)
not available

Further information on the trial
not available

Results of the trial

Results summary

not available

Link to the results in the primary register

not available